Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates.. IndiaTimes
A study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI)... IndiaTimes
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The.. IndiaTimes
UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to.. IndiaTimes
![AstraZeneca pulls its COVID-19 vaccine from the European market [Video]](https://video.newsserve.net/300/v/20240509/1375060834-AstraZeneca-pulls-its-COVID-19-vaccine-from-the.jpg)
![AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]](https://video.newsserve.net/300/v/20240508/1375014316-AstraZeneca-requests-European-authorisation-of-Covid-vaccine-be.jpg)
